Hypophysectomy differentially alters P-450 protein levels and enzyme activities in rat liver: pituitary control of hepatic NADPH cytochrome P-450 reductase

DJ Waxman, JJ Morrissey and GA Leblanc

Department of Biological Chemistry, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115.

Pituitary-determined hormones regulate the expression of hepatic cytochromes P-450 through processes involving both negative and positive controls. Accordingly, protein levels of several P-450 forms are elevated in rat liver following hypophysectomy [P-450 forms designated 2a (gene IIIA2), RLM2 (gene IIA2), and PB-4 (gene IIB1)], whereas protein levels of others are suppressed [e.g., P-450 2c (gene IIC11)]. In the present study, microsomal steroid hydroxylase activities associated with these same P-450 forms were found to be decreased by hypophysectomy, despite elevations in protein levels for several of them. Studies were, therefore, undertaken to determine the biochemical basis for this decrease in microsomal P-450 enzyme specific activity. In vivo treatment of hypophysectomized rats with gonadotropin, under conditions that restore heme to testis P-450, and heme reconstitution experiments carried out with liver homogenates indicated that a deficiency in P-450-associated heme is unlikely to account for the observed decreases in liver P-450 enzyme specific activity. Analysis of the flavoprotein P-450 reductase, however, revealed that the reductase protein and its associated cytochrome c reductase activity are decreased by 50 to 75% in liver microsomes isolated from hypophysectomized rats. Moreover, supplementation of isolated liver microsomes with exogenous purified P-450 reductase stimulated microsomal steroid hydroxylase activity preferentially in the hypophysectomized rats, to levels consistent with the observed changes in P-450 protein levels. Thus, a deficiency in P-450 reductase, which is a rate-limiting component for many P-450-dependent hydroxylation reactions, appears to be responsible for the decrease in steroid hydroxylase specific activity in the hypophysectomized rats. Although growth hormone, adrenocorticotropic hormone, and chorionic gonadotropin were each ineffective at restoring hepatic P-450 reductase when administered to hypophysectomized rats, substantial restoration of P-450 reductase levels could be achieved by treatment of the hypophysectomized rats with thyroxine. Thyroxine treatment of these rats also elevated the microsomal steroid hydroxylase activities associated with the individual hepatic P-450 forms to levels commensurate with their respective P-450 protein levels. These results establish that hepatic P-450 reductase is subject to hormonal controls that are distinct from those governing cytochrome P-450 expression and further demonstrate the complexity of endocrine control of hepatic steroid hormone metabolism.

Volume 35, Issue 4, pp. 519-525, 04/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				F. Gueraud, D. Daveloose, H. Vezin, J. Viret, and A. Paris In Vivo Modification of the UDP-Glucuronosyltransferase Functional State in Rat Liver Following Hypophysectomy and Partial or Complete Hormonal Restoration J. Biochem., November 1, 2003; 134(5): 641 - 653. [Abstract] [Full Text] [PDF]

				H. C. Chung, S. H. Kim, M. G. Lee, and S. G. Kim Increase in Urea in Conjunction with L-Arginine Metabolism in the Liver Leads to Induction of Cytochrome P450 2E1 (CYP2E1): The Role of Urea in CYP2E1 Induction by Acute Renal Failure Drug Metab. Dispos., June 1, 2002; 30(6): 739 - 746. [Abstract] [Full Text] [PDF]

				D. Liu and D. J. Waxman Post-Transcriptional Regulation of Hepatic NADPH-Cytochrome P450 Reductase by Thyroid Hormone: Independent Effects on Poly(A) Tail Length and mRNA Stability Mol. Pharmacol., May 1, 2002; 61(5): 1089 - 1096. [Abstract] [Full Text] [PDF]

				H.-C. Li, D. Liu, and D. J. Waxman Transcriptional Induction of Hepatic NADPH: Cytochrome P450 Oxidoreductase by Thyroid Hormone Mol. Pharmacol., April 16, 2001; 59(5): 987 - 995. [Abstract] [Full Text]

				K. A. O'Leary, H.-C. Li, P. A. Ram, P. McQuiddy, D. J. Waxman, and C. B. Kasper Thyroid Regulation of NADPH:Cytochrome P450 Oxidoreductase: Identification of a Thyroid-Responsive Element in the 5'-Flank of the Oxidoreductase Gene Mol. Pharmacol., July 1, 1997; 52(1): 46 - 53. [Abstract] [Full Text]